How would you like your name to appear on your certificate?

Profession

What activities did you attend at the event?

Friday September 11, 2009 8:30 -10:00 a.m

Friday September 11, 2009 10:30 - 12:00 p.m

Friday September 11, 2009 12:00 - 1:15 p.m

Friday September 11, 2009 1:30 - 2:30 p.m

Friday September 11, 2009 2:45 - 4:15 p.m

Friday September 11, 2009 4:45 - 5:45 p.m

Saturday September 12, 2009 8:30 - 10:00 a.m

Saturday September 12, 2009 10:30 - 12:00 p.m Dual Track Sessions

Saturday September 12, 2009 1:30 - 2:30 p.m

Saturday September 12, 2009 2:45- 4:15 p.m Dual Track Sessions

Saturday September 12, 2009 4:45- 5:45 p.m

Agreement

By completing this form, you attest that you have participated in all selected activities in thier entirety.

I agree

Please rate the following:

The program was relevant to my work.

Content matched stated objectives.

Usefulness of handouts/AV.

Quality of facilities.

How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?

If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain:

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Please rate the speaker Robin Murray. You will have the opportunity to elaborate on an in the following question.

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Please rate the speaker Jill Hooley. You will have the opportunity to elaborate on an in the following question.

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Please rate the speaker Kenneth S. Kendler. You will have the opportunity to elaborate on in the following question.

Please rate the speaker(s) as a group. You will have the opportunity to elaborate on an individual speaker in the following question.

Please rate the speaker Constance Hammen. You will have the opportunity to elaborate in the following question.

Objective 1: Identify and explain current trends in the definition and categorization of psychopathology

The above objective will increase my professional competence.

The above objective will result in changes to performance in my professional practice.

The above objective will result in improved patient outcomes.

If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:

Objective 2: Explain current thinking about the etiology of schizophrenia and the major mood disorders..

The above objective will increase my professional competence.

The above objective will result in changes to performance in my professional practice.

The above objective will result in improved patient outcomes.

Objective 3: Describe current treatment approaches to schizophrenia and the major mood disorders that are informed by basic psychopathology research.

The above objective will increase my professional competence.

The above objective will result in changes to performance in my professional practice.

The above objective will result in improved patient outcomes.

Discuss current and emerging interventions to prevent the occurrence or recurrence of mood and psychotic disorders.

Describe current approaches to assessing and predicting functional disability in individuals with schizophrenia and mood disorders.

Describe recent changes to the NIH’s grant review procedures.

Use the presenters’ suggestions to improve grant writing and the ability to respond successfully to grant reviews

Explain how striatal dopamine dysregulation serves as the final common pathway for psychosis.

List and describe several environmental risk factors for schizophrenia, including cannabis use.

Explain what is meant by the "dimensional" nature of psychosis.

Discuss evidence indicating that HPA markers can be used to predict vulnerability to major depression.

Discuss the evidence that individual differences in the clinical features of depression are associated with HPA functioning.

Explain current developments in the definition and classification of self-injurious behavior including current proposals for DSM-V.

Describe the prevalence of non-suicidal self-injury (NSSI) and some of the demographic factors associated with elevated risk for NSSI.

Describe new findings from experimental research designed to investigate pain perception in people who engage in self-harming behaviors.

Identify cognitive, affective and genetic factors that predict functional disability in individuals with schizophrenia.

Describe emerging approaches to evaluating personality disorders.

Discuss evidence that that genotype and life stress interact to predict risk and symptomology in depression.

Explain current thinking about the association between depression risk genes and cognitive impairment.

Discuss the nature and inter-relationships of the four major paradigms used in psychiatric genetics.

Distinguish the differences between gene-environment correlation and interaction.

Describe the basic principles of genome-wide association studies.

Identify and discuss emerging behavioral and genetic indicators of risk for psychopathology.

Identify cognitive deficits in people with schizophrenia that are improved by cognitive remediation training.

Discuss evidence that cognitive remediation training restores normal neural operations in brain areas affected by schizophrenia.

Discuss evidence that EEG can be used to assess therapeutic improvement associated with cognitive remediation training.

Discuss historical trends in depression research strategies in recent decades.

Define "stress generation" and its implications and predictors.

Discuss mechanisms that help explain how depression runs in families.

Please answer the following:

Do you believe this activity was appropriate for the scope of your professional activities?

Was the educational content scientifically sound?

Was the educational content free of commercial bias?

Was the mode of education effective to learning?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

If you answered "No" to any of the above questions, please explain.

Were you solicited by sales personnel in an educational room while you attended this educational activity?

If you answered "Yes" to the above question, please explain.

How much did you learn as a result of this educational program?

What did you learn during this activity that you intend to integrate into your practice?

My professional competence would be improved if I had training on:

My professional performance would be improved if I had training on:

My patient outcomes would be improved if I had training on:

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training be improved to better impact competence, performance and/or patient outcomes?

Additional comments: